- Home
- CTVA vs IDXX Comparison
CTVA vs IDXX Comparison
Compare CTVA & IDXX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTVA
- IDXX
- Stock Information
- Founded
- CTVA 2018
- IDXX 1983
- Country
- CTVA United States
- IDXX United States
- Employees
- CTVA N/A
- IDXX N/A
- Industry
- CTVA Farming/Seeds/Milling
- IDXX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- CTVA Consumer Staples
- IDXX Health Care
- Exchange
- CTVA Nasdaq
- IDXX Nasdaq
- Market Cap
- CTVA 38.8B
- IDXX 39.8B
- IPO Year
- CTVA N/A
- IDXX 1991
- Fundamental
- Price
- CTVA $58.96
- IDXX $458.32
- Analyst Decision
- CTVA Buy
- IDXX Buy
- Analyst Count
- CTVA 21
- IDXX 7
- Target Price
- CTVA $61.74
- IDXX $570.14
- AVG Volume (30 Days)
- CTVA 2.7M
- IDXX 435.4K
- Earning Date
- CTVA 11-06-2024
- IDXX 10-31-2024
- Dividend Yield
- CTVA 1.15%
- IDXX N/A
- EPS Growth
- CTVA N/A
- IDXX 6.85
- EPS
- CTVA 1.27
- IDXX 10.08
- Revenue
- CTVA $16,901,000,000.00
- IDXX $3,784,801,000.00
- Revenue This Year
- CTVA $2.07
- IDXX $9.18
- Revenue Next Year
- CTVA $4.15
- IDXX $8.83
- P/E Ratio
- CTVA $46.59
- IDXX $45.64
- Revenue Growth
- CTVA N/A
- IDXX 7.70
- 52 Week Low
- CTVA $43.22
- IDXX $372.50
- 52 Week High
- CTVA $59.13
- IDXX $583.39
- Technical
- Relative Strength Index (RSI)
- CTVA 61.12
- IDXX 36.01
- Support Level
- CTVA $56.45
- IDXX $460.36
- Resistance Level
- CTVA $57.83
- IDXX $486.87
- Average True Range (ATR)
- CTVA 0.87
- IDXX 10.00
- MACD
- CTVA -0.00
- IDXX -2.70
- Stochastic Oscillator
- CTVA 95.23
- IDXX 10.87
About CTVA Corteva Inc.
Corteva is an agricultural inputs pure play that was formed in 2019 when it was spun off from DowDuPont. The company is a leader in the development of new seed and crop protection products. Seeds generate the majority of profits with the remainder coming from crop protection products. Corteva operates globally, but around half of revenue comes from North America.
About IDXX IDEXX Laboratories Inc.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets close to 35% of its revenue from outside the United States.